Dashboard

Structure Therapeutics Inc.

GPCRNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$3.5B

Price$49.1252w $16.20 – $93.79

Conviction2/ 5

Revenue (TTM)$0

Revenue growth YoY-100.0%

P/E (trailing)—

Gross margin—

Operating margin—

Net margin—

52w price change+125.4%

Next earningsAug 5, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Jul 24
Ownership changeSEC
SEC Form 4 insider transaction filing dated 2026-07-24.
Jul 15
Ownership changeSEC
SEC Form 4 filing reporting change in insider beneficial ownership.
Jun 29
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 18
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jun 18
Ownership changeSEC
SEC Form 4 insider transaction filing
Jun 18
Ownership changeSEC
SEC Form 4 insider transaction filing dated 2026-06-18.
Jun 18
OtherSEC
8-K filing item 5.07 disclosing results of matters submitted to shareholder vote.
Jun 18
Ownership changeSEC
Form 4 insider transaction filing by Structure Therapeutics Inc.
Jun 18
Ownership changeSEC
SEC Form 4 insider transaction filing on 2026-06-18.
Jun 18
Ownership changeSEC
SEC Form 4 insider transaction filing.
May 7
Financial resultsSEC
8-K filing (items 1.01,2.02,8.01,9.01) covering material agreement and financial results.
May 7
Securities offeringSEC
Structure Therapeutics filed Form 424B5 prospectus supplement.

Not financial advice — research and opinion only. Disclosures